Home・Lista de Ações・Abbott Laboratories

Abbott Laboratories

Fechado

SetorSaúde

111.27 0.03

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

110.66

Máximo

111.96

Indicadores-chave
By Trading Economics
Rendimento	-149M 928M
Vendas	1.4B 13B
P/E Médio do Setor	34.814 57.002
EPS	1.31
Rendimento de Dividendos	2.3
Margem de lucro	7.369
Funcionários	122,000
EBITDA	-465M 1.8B

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+9.45% upside

Dividendos
By Acuity
Rendimento de Dividendos Médio do Setor	2.30% 2.22%
Próximos Ganhos	14 de out. de 2026
Próxima data de dividendos	17 de ago. de 2026
Próxima data de ex-dividendo	14 de out. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	24B 188B
Abertura anterior	111.24
Fecho anterior	111.27

Sentimento de Notícias

By Acuity

22%

78%

73 / 340 Ranking em Healthcare

Abbott Laboratories Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

14 de ago. de 2026, 23:02 UTC

Abbott Laboratories shares are trading higher in after-market hours, showing strength above the 20-day moving average despite mixed market sentiment and declining U.S. retail sales.

13 de ago. de 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market trading, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

12 de ago. de 2026, 23:46 UTC

Abbott Laboratories shares are lower in after-market trading, with no specific news identified for the decline. Broader market optimism follows recent inflation data.

11 de ago. de 2026, 19:16 UTC

News

Abbott Laboratories announced a partnership with Google Health to enhance glucose management through AI. Shares are trading higher amid positive market sentiment.

10 de ago. de 2026, 23:46 UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified for the decline. The stock remains above its 20-day moving average.

7 de ago. de 2026, 23:06 UTC

Abbott Laboratories shares declined slightly in after-market trading. The stock remains above its 20-day moving average and near the upper end of its one-month range.

6 de ago. de 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market hours, amid broader market weakness and rising initial jobless claims contributing to tightening expectations.

5 de ago. de 2026, 23:02 UTC

Abbott Laboratories shares are lower in after-market trading, following a brief peak post-close. Broader market conditions may be influencing sentiment amid weaker U.S. job growth data.

4 de ago. de 2026, 20:06 UTC

Abbott Laboratories shares are lower today, tracking broader market declines amid falling crude oil prices and ongoing discussions about potential peace talks.

3 de ago. de 2026, 23:06 UTC

Abbott Laboratories shares are near unchanged in after-market trading, positioned 7.52% above the 20-day moving average and near the upper end of the one-month range.

31 de jul. de 2026, 23:01 UTC

Abbott Laboratories shares are modestly higher in after-market trading. The stock remains elevated, 7.16% above its 20-day moving average.

30 de jul. de 2026, 23:51 UTC

Abbott Laboratories shares are higher in after-market trading, recovering from earlier losses. The stock trades significantly above its 20-day moving average.

29 de jul. de 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market hours, continuing recent volatility amid mixed global market performance and rising geopolitical tensions in the Middle East.

28 de jul. de 2026, 23:02 UTC

Abbott Laboratories shares are higher in after-market hours, showing notable volatility post-close while remaining above the 20-day moving average. No specific news was identified.

27 de jul. de 2026, 23:02 UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified to explain the movement. Broader market sentiment may be influencing the decline.

24 de jul. de 2026, 20:02 UTC

News

A court dismissed a shareholder lawsuit regarding Abbott Laboratories' 2022 infant formula recall, boosting market sentiment as shares trade higher with increased volume.

23 de jul. de 2026, 23:41 UTC

Abbott Laboratories shares are lower in after-market hours amid broader market weakness, particularly in the bond market, with no specific company news identified.

22 de jul. de 2026, 22:06 UTC

Abbott Laboratories shares are higher in after-market trading, positioned above their 20-day moving average and near the upper end of their one-month trading range.

21 de jul. de 2026, 19:01 UTC

Abbott Laboratories is lower today, continuing a decline that began Monday. The stock has dropped from an early peak amid no specific news.

20 de jul. de 2026, 23:06 UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified. Broader market volatility stems from rising Treasury yields and geopolitical tensions.

Comparação entre Pares

Variação de preço

Abbott Laboratories Previsão

Preço-alvo

By TipRanks

9.45% parte superior

Previsão para 12 meses

Média 121.79 USD 9.45%

Máximo 135 USD

Mínimo 112 USD

Com base em 16 analistas de Wall Street que oferecem metas de preço de 12 meses para Abbott Laboratories - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

16 ratings

Comprar

Manter

Vender

Com base em 16 analistas que deram avaliações de ações para Abbott Laboratories - Dist nos últimos 3 meses.

Sentimento

By Acuity

73 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.